Abstract
Thyroid hormone (TH) activates PI3K and Akt, leading to glucose uptake in rat skeletal
muscle cells and proliferation of insulinoma cells, respectively. However, TH actions
on pancreatic beta cells have been little explored, which lead us to evaluate the
TH effects on proinsulin gene expression, and the involvement of PI3K/Akt/GSK-3β signaling
pathway, and a transcriptional factor for insulin (PDX-1). INS-1E cells were sorted
into 3 groups: control and TH-depleted treated or not with T3 for 30 min. Cells were
also previously treated with actinomycin D (ActD), cycloheximide (CHX), wortmannin
or Akt inhibitor. Proinsulin mRNA expression was evaluated by real time PCR, and pGSK-3β
and PDX-1 protein content was analyzed by Western blotting. TH depletion decreased
proinsulin mRNA content, which was restored after acute T3 treatment. ActD, CHX and
wortmannin, but not Akt inhibitor, prevented the rapid stimulatory effect of T3 on
proinsulin mRNA expression. TH depletion did not affect the phosphorylated GSK-3β
and PDX-1 protein content; but T3 treatment led to an increase in the content of these
proteins. These data indicate that T3 acutely increases proinsulin mRNA expression,
by mechanisms which depends on the activation of PI3K, but not of Akt, and may involve
the inactivation of GSK-3β by phosphorylation. Since GSK-3β enhances PDX-1 degradation
rate, the GSK-3β inactivation could explain the increase of PDX-1 content in T3-treated
cells. Considering that PDX-1 is one of the most important transcriptional factors
for proinsulin gene expression, its enhancement may underlie the increased proinsulin
mRNA content acutely induced by T3.
Key words
proinsulin gene expression - triiodothyronine (T3) - transcriptional factor PDX-1
- PI3K/Akt signaling - phosphorylated GSK-3β